Andrew S. Dixon, Ph.D.

2011 Pharmaceutics and Pharmaceutical Chemistry University of Utah, Salt Lake City, UT 
Pharmacy, Biochemistry, Oncology
"Andrew Dixon"
Mean distance: (not calculated yet)


Sign in to add mentor
Carol S. Lim grad student 2011 University of Utah
 (Capture of Bcr-Abl for induction of apoptosis in chronic myelogenous leukemia: From inhibition to nuclear escort.)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Okal A, Mossalam M, Matissek KJ, et al. (2013) A chimeric p53 evades mutant p53 transdominant inhibition in cancer cells. Molecular Pharmaceutics. 10: 3922-33
Dixon AS, Miller GD, Bruno BJ, et al. (2012) Correction to "improved coiled-coil design enhances interaction with bcr-abl and induces apoptosis". Molecular Pharmaceutics. 9: 1535
Dixon AS, Constance JE, Tanaka T, et al. (2012) Changing the subcellular location of the oncoprotein Bcr-Abl using rationally designed capture motifs. Pharmaceutical Research. 29: 1098-109
Dixon AS, Miller GD, Bruno BJ, et al. (2012) Improved coiled-coil design enhances interaction with Bcr-Abl and induces apoptosis. Molecular Pharmaceutics. 9: 187-95
Dixon AS, Pendley SS, Bruno BJ, et al. (2011) Disruption of Bcr-Abl coiled coil oligomerization by design. The Journal of Biological Chemistry. 286: 27751-60
Mossalam M, Dixon AS, Lim CS. (2010) Controlling subcellular delivery to optimize therapeutic effect. Therapeutic Delivery. 1: 169-93
Dixon AS, Lim CS. (2010) The nuclear translocation assay for intracellular protein-protein interactions and its application to the Bcr coiled-coil domain. Biotechniques. 49: 519-24
Dixon AS, Kakar M, Schneider KM, et al. (2009) Controlling subcellular localization to alter function: Sending oncogenic Bcr-Abl to the nucleus causes apoptosis. Journal of Controlled Release : Official Journal of the Controlled Release Society. 140: 245-9
See more...